These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12955445)

  • 21. Efficacy of latanoprost in patients with chronic angle-closure glaucoma and no visible ciliary-body face: a preliminary study.
    Kook MS; Cho HS; Yang SJ; Kim S; Chung J
    J Ocul Pharmacol Ther; 2005 Feb; 21(1):75-84. PubMed ID: 15718831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of latanoprost in eyes with uveitic glaucoma.
    Markomichelakis NN; Kostakou A; Halkiadakis I; Chalkidou S; Papakonstantinou D; Georgopoulos G
    Graefes Arch Clin Exp Ophthalmol; 2009 Jun; 247(6):775-80. PubMed ID: 19184081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Timolol + latanoprost: new preparation. Last-resort eye drops.
    Prescrire Int; 2003 Oct; 12(67):173-4. PubMed ID: 14619889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effectiveness of latanoprost for the treatment of pediatric glaucoma.
    Enyedi LB; Freedman SF; Buckley EG
    J AAPOS; 1999 Feb; 3(1):33-9. PubMed ID: 10071899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 24-hour efficacy of the bimatoprost-timolol fixed combination versus latanoprost as first choice therapy in subjects with high-pressure exfoliation syndrome and glaucoma.
    Konstas AG; Holló G; Mikropoulos DG; Haidich AB; Dimopoulos AT; Empeslidis T; Teus MA; Ritch R
    Br J Ophthalmol; 2013 Jul; 97(7):857-61. PubMed ID: 23686322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intraocular pressure lowering effect of brinzolamide 1.0% as adjunctive therapy to latanoprost 0.005% in patients with open angle glaucoma or ocular hypertension: an uncontrolled, open-label study.
    Shoji N; Ogata H; Suyama H; Ishikawa H; Suzuki H; Morita T; Kawai H; Nishimoto H; Nemoto T; Shimizu K
    Curr Med Res Opin; 2005 Apr; 21(4):503-8. PubMed ID: 15899098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of latanoprost eye drops for glaucoma treatment: a 1-year study in Japan.
    Suzuki M; Mishima HK; Masuda K; Araie M; Kitazawa Y; Azuma I
    Jpn J Ophthalmol; 2000; 44(1):33-8. PubMed ID: 10698023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 5-year, multicenter, open-label, safety study of adjunctive latanoprost therapy for glaucoma.
    Alm A; Schoenfelder J; McDermott J
    Arch Ophthalmol; 2004 Jul; 122(7):957-65. PubMed ID: 15249358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Four years later: a clinical update on latanoprost.
    Ravinet E; Mermoud A; Brignoli R
    Eur J Ophthalmol; 2003 Mar; 13(2):162-75. PubMed ID: 12696636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group.
    Camras CB
    Ophthalmology; 1996 Jan; 103(1):138-47. PubMed ID: 8628544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of iris colour change in latanoprost treated eyes.
    Teus MA; Arranz-Márquez E; Lucea-Suescun P
    Br J Ophthalmol; 2002 Oct; 86(10):1085-8. PubMed ID: 12234883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective study of iridial pigmentation and eyelash changes due to ophthalmic treatment with latanoprost.
    Chiba T; Kashiwagi K; Ishijima K; Furuichi M; Kogure S; Abe K; Chiba N; Tsukahara S
    Jpn J Ophthalmol; 2004; 48(2):141-7. PubMed ID: 15060793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of the efficacy and tolerability of brimonidine and latanoprost in adults with open-angle glaucoma or ocular hypertension: a three-month, multicenter, randomized, double-masked, parallel-group trial.
    DuBiner HB; Mroz M; Shapiro AM; Dirks MS;
    Clin Ther; 2001 Dec; 23(12):1969-83. PubMed ID: 11813932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized, 36-month, post-marketing efficacy and tolerability study in Sweden and Finland of latanoprost versus non-prostaglandin therapy in patients with glaucoma or ocular hypertension.
    Friström B; Uusitalo H
    Acta Ophthalmol; 2010 Feb; 88(1):37-43. PubMed ID: 19900212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased eyelid pigmentation associated with use of latanoprost.
    Kook MS; Lee K
    Am J Ophthalmol; 2000 Jun; 129(6):804-6. PubMed ID: 10926995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group.
    Watson P; Stjernschantz J
    Ophthalmology; 1996 Jan; 103(1):126-37. PubMed ID: 8628543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of additional intraocular pressure reduction in patients changed to latanoprost/timolol fixed combination.
    Sellem E; Rouland JF; Baudouin C; Bron A; Denis P; Nordmann JP; Renard JP
    BMC Ophthalmol; 2010 Mar; 10():10. PubMed ID: 20346127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of travoprost, latanoprost, and the fixed combination of dorzolamide and timolol in patients with pseudoexfoliation glaucoma.
    Parmaksiz S; Yüksel N; Karabas VL; Ozkan B; Demirci G; Caglar Y
    Eur J Ophthalmol; 2006; 16(1):73-80. PubMed ID: 16496249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraocular pressure after replacement of current dual therapy with latanoprost monotherapy in patients with open angle glaucoma.
    Pillunat LE; Larsson LI;
    Br J Ophthalmol; 2003 Dec; 87(12):1492-6. PubMed ID: 14660460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Five-year, multicenter safety study of fixed-combination latanoprost/timolol (Xalacom) for open-angle glaucoma and ocular hypertension.
    Alm A; Grunden JW; Kwok KK
    J Glaucoma; 2011; 20(4):215-22. PubMed ID: 20520568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.